Analytical MethodsDetermination of total Avilamycin (cas 11051-71-1) residues as dichloroisoeverninic acid in porcine muscle, fat, and liver by LC-MS/MS
-
Add time:08/16/2019 Source:sciencedirect.com
A sensitive and reliable method for determining the total Avilamycin (cas 11051-71-1) residues was developed using LC–MS/MS. Avilamycin (consisting of avilamycin A and 15 other minor factors) and its metabolites in porcine muscle, fat, and liver were analysed as the marker residue dichloroisoeverninic acid (DIA), in accordance with the maximum residue limit (MRL) established by international organisations such as Codex Alimentarius Commission and other regulatory bodies. The analytes were extracted from samples with acetone, hydrolysed to DIA, partitioned into ethyl acetate, and cleaned up prior to the LC-MS/MS analysis. The method was validated at Codex MRL and 0.01 mg/kg. The results show excellent recoveries ranging from 100 to 108%, with the relative standard deviations <6%. Matrix effects were negligible for all types of samples, indicating effective sample clean-up. The absence of interfering peaks close to the retention time in blank samples demonstrates high selectivity. Overall, this method is reliable and suitable for regulatory-purpose analysis.
We also recommend Trading Suppliers and Manufacturers of Avilamycin (cas 11051-71-1). Pls Click Website Link as below: cas 11051-71-1 suppliers
Prev:Membrane plasticity facilitates recognition of the inhibitor OLIGOMYCIN B (cas 11050-94-5)y the mitochondrial ATP synthase rotor☆
Next:Use of Avilamycin (cas 11051-71-1) for growth promotion and Avilamycin (cas 11051-71-1)-resistance among Enterococcus faecium from broilers in a matched case–control study in France) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleGenes Encoding Enzymes Responsible for Biosynthesis of L-Lyxose and Attachment of Eurekanate during Avilamycin (cas 11051-71-1) Biosynthesis08/21/2019
- Research PaperBiosynthesis of the orthosomycin antibiotic Avilamycin (cas 11051-71-1) A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics08/20/2019
- Short communicationDetermination of Avilamycin (cas 11051-71-1) A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay08/19/2019
- ArticleNovel Avilamycin (cas 11051-71-1) Derivatives with Improved Polarity Generated by Targeted Gene Disruption08/18/2019
- Use of Avilamycin (cas 11051-71-1) for growth promotion and Avilamycin (cas 11051-71-1)-resistance among Enterococcus faecium from broilers in a matched case–control study in France08/17/2019


